CABG Cabg Medical (MM)

MINNEAPOLIS, Aug. 29 /PRNewswire-FirstCall/ -- CABG Medical, Inc. (NASDAQ:CABG) today announced that it will present at the Roth Capital Partners New York Conference on September 7, 2005 at 9:00 a.m. Eastern Daylight Time. The presentation will include discussions of our human clinical trials, a strategic overview and review of historical financial performance. Presenting will be Manny Villafana, Chairman and Chief Executive Officer, who has previously introduced innovative cardiac surgery products such as pacemakers and heart valves throughout the world and founded companies such as Cardiac Pacemakers, Inc. (now Guidant Corporation), St. Jude Medical, Inc. and ATS Medical, Inc. (Logo: http://www.newscom.com/cgi-bin/prnh/20050114/CGF013LOGO ) Attendance at the Roth Capital Partners New York Conference is by invitation only. A live audio-only webcast of the presentation, hosted by Roth Capital, will also be broadcast via the Internet. Those interested in listening to the webcast may access it through the "investor relations" section of CABG Medical's website http://www.cabgmedical.com/investorRelations.html or at http://www.wsw.com/webcast/roth6/cabg . An archived replay of the presentation will also be available approximately one hour following the live presentation and will remain accessible for 90 days. About CABG Medical CABG Medical, Inc. is a medical technology company developing technologies and therapies to improve the treatment of coronary heart disease by advancing conventional bypass surgery. We have designed our first product, the Holly Graft(TM) System, by leveraging our understanding of flow dynamics, material sciences and drug combinations to create a drug-eluting graft (DEG) for coronary artery bypass surgery. Safe Harbor This Press Release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of important factors, including regulatory actions, competition, and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission. http://www.newscom.com/cgi-bin/prnh/20050114/CGF013LOGO http://photoarchive.ap.org/ DATASOURCE: CABG Medical, Inc. CONTACT: Manny Villafana, Chairman & CEO, or John L. Babitt, President, both of CABG Medical, Inc., +1-763-258-8005, fax +1-763-258-8008 Web site: http://www.cabgmedical.com/ http://www.cabgmedical.com/investorRelations.html http://www.wsw.com/webcast/roth6/cabg

Copyright